The key differentiator between RTM platforms is whether the patients need to wear sensors and/or wearables or if the technology is so advanced that the technology can track the patients’ movements without wearables simply through a smart device or computer. What is RTM an...
how workloads will be managed while people are gone and how workloads will be managed when employees return. I reached out to some professionals who are doing work in this space to help Black professionals “call in Black”,take time to rest, or go to therapy in the middle of ...
Stem cell therapy for human neurodegenerative disorders-how to make it work. Recent progress shows that neurons suitable for transplantation can be generated from stem cells in culture, and that the adult brain produces new neurons ... Lindvall,Olle,Kokaia,... - 《Nature Medicine》 被引量: 15...
Cell-permeable agonists also work [10]. However, their therapeutic potential is limited, because in vivo their efficacy as pharmacochaperones is compounded by agonist-induced desensitization of the receptor. The pharmacochaperoning action of orthosteric ligands relies—at least in part—on the presence...
gondii-specific activated T-cells than patients who discontinued the maintenance therapy and were relapse-free. This data suggests that the evaluation of T. gondii-specific immune responses by Elispot can improve the estimates of the individual risk of TE and TE relapses. Trypanosoma cruzi is the...